MIRM
Mirum Pharmaceuticals Inc
92.00$
+0.2%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 100.0% | 81.4% | 98.1% | 56.5% | 53.9% | 59.9% | 58.6% | 65.2% | |
| 100.0% | 8.2% | 59.0% | 10.6% | 7.9% | 44.3% | 33.2% | 35.2% | |
| 100.0% | 79.5% | 96.2% | 53.1% | 43.0% | 44.3% | 41.8% | 45.5% | |
| – | – | 0.0% | 1.5% | 6.8% | 10.5% | 11.7% | 14.6% | |
| 0.0% | – | 0.0% | 0.5% | 1.6% | 3.5% | 3.3% | 3.0% | |
| 0.0% | 2.5% | 0.5% | 0.3% | 0.3% | – | – | – | |
| 0.0% | – | – | – | – | – | – | – | |
| 0.0% | – | – | 6.4% | 16.7% | 39.1% | 37.2% | 31.0% | |
| 119.9% | 11.2% | 28.6% | 59.2% | 59.8% | 61.5% | 66.4% | 62.7% | |
| 4.7% | 8.9% | 7.7% | 14.5% | 18.3% | 13.5% | 18.9% | 24.4% | |
| 0.0% | 0.3% | 0.3% | 0.2% | 0.3% | 0.2% | 0.3% | 0.3% | |
| 0.5% | 2.3% | 1.3% | 3.1% | 2.5% | 1.1% | 2.2% | 1.1% | |
| 0.0% | – | – | – | – | 47.4% | 45.9% | 36.8% | |
| -19.9% | 88.8% | 71.4% | 40.8% | 40.2% | 38.5% | 33.6% | 37.3% | |
| -33.4% | -47.6% | -71.9% | -87.3% | -111.3% | -86.0% | -96.0% | -79.2% | |
| 44.2% | 15.7% | 10.5% | 10.3% | 9.6% | 6.3% | 7.1% | 6.0% |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.